InfuSystem Holdings Management

Management criteria checks 2/4

InfuSystem Holdings' CEO is Rich DiIorio, appointed in Nov 2017, has a tenure of 6.42 years. total yearly compensation is $2.29M, comprised of 26.2% salary and 73.8% bonuses, including company stock and options. directly owns 2% of the company’s shares, worth $3.23M. The average tenure of the management team and the board of directors is 4.3 years and 5.7 years respectively.

Key information

Rich DiIorio

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage	26.2%
CEO tenure	6.4yrs
CEO ownership	2.0%
Management average tenure	4.3yrs
Board average tenure	5.7yrs

Recent management updates

Recent updates

If You Like EPS Growth Then Check Out InfuSystem Holdings (NYSEMKT:INFU) Before It's Too Late

Feb 19

Will InfuSystem Holdings' (NYSEMKT:INFU) Growth In ROCE Persist?

Feb 06

InfuSystem Holdings (NYSEMKT:INFU) Seems To Use Debt Quite Sensibly

Jan 24

If You Had Bought InfuSystem Holdings (NYSEMKT:INFU) Shares Three Years Ago You'd Have Earned 625% Returns

Jan 11

At US$18.99, Is InfuSystem Holdings Inc. (NYSEMKT:INFU) Worth Looking At Closely?

Dec 28

CEO Compensation Analysis

How has Rich DiIorio's remuneration changed compared to InfuSystem Holdings's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$2m	US$600k	US$872k
Sep 30 2023	n/a	n/a	US$907k
Jun 30 2023	n/a	n/a	US$661k
Mar 31 2023	n/a	n/a	US$62k
Dec 31 2022	US$2m	US$600k	US$18k
Sep 30 2022	n/a	n/a	US$298k
Jun 30 2022	n/a	n/a	-US$593k
Mar 31 2022	n/a	n/a	US$391k
Dec 31 2021	US$2m	US$550k	US$1m
Sep 30 2021	n/a	n/a	US$12m
Jun 30 2021	n/a	n/a	US$15m
Mar 31 2021	n/a	n/a	US$18m
Dec 31 2020	US$3m	US$450k	US$17m
Sep 30 2020	n/a	n/a	US$7m
Jun 30 2020	n/a	n/a	US$6m
Mar 31 2020	n/a	n/a	US$2m
Dec 31 2019	US$606k	US$339k	US$1m
Sep 30 2019	n/a	n/a	US$281k
Jun 30 2019	n/a	n/a	-US$1m
Mar 31 2019	n/a	n/a	-US$2m
Dec 31 2018	US$1m	US$312k	-US$1m
Sep 30 2018	n/a	n/a	-US$19m
Jun 30 2018	n/a	n/a	-US$18m
Mar 31 2018	n/a	n/a	-US$19m
Dec 31 2017	US$635k	US$235k	-US$21m

Compensation vs Market: Rich's total compensation ($USD2.29M) is above average for companies of similar size in the US market ($USD1.60M).

Compensation vs Earnings: Rich's compensation has increased by more than 20% in the past year.

CEO

Rich DiIorio (48 yo)

6.4yrs

Tenure

US$2,286,657

Compensation

Mr. Richard A. DiIorio, also known as Rich, joined InfuSystem Holdings Inc. in 2004 and serves as its Chief Executive Officer and Director since November 15, 2017. He served as President at InfuSystem Hold...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Richard DiIorio	CEO & Director	6.4yrs	US$2.29m	2% $ 3.2m
Carrie Lachance	President	4.5yrs	US$1.26m	0.68% $ 1.1m
Barry Steele	Executive VP & CFO	4.1yrs	US$1.15m	0.28% $ 453.9k
Addam Chupa	Executive VP & Chief Information Officer	no data	no data	0.099% $ 159.9k
Jerod Funke	Executive VP & Chief HR Officer	less than a year	no data	no data
Jeanie Latz	Corporate Secretary	no data	no data	no data

4.3yrs

Average Tenure

48yo

Average Age

Experienced Management: INFU's management team is considered experienced (4.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Richard DiIorio	CEO & Director	6.4yrs	US$2.29m	2% $ 3.2m
Carrie Lachance	President	2.9yrs	US$1.26m	0.68% $ 1.1m
Scott Shuda	Independent Chairman of the Board	7.6yrs	US$196.73k	0.43% $ 688.7k
Ralph Boyd	Independent Director	1.9yrs	US$167.41k	0.0094% $ 15.2k
Gregg Lehman	Independent Director	9.9yrs	US$168.97k	0.0016% $ 2.6k
Paul Gendron	Independent Director	4.9yrs	US$179.59k	0.28% $ 456.6k

5.7yrs

Average Tenure

59.5yo

Average Age

Experienced Board: INFU's board of directors are considered experienced (5.7 years average tenure).

InfuSystem Holdings Management

Management criteria checks 2/4

Key information

Recent management updates

InfuSystem Holdings, Inc., Annual General Meeting, May 16, 2024

InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board

CEO & Director exercised options and sold US$870k worth of stock

President exercised options and sold US$79k worth of stock

Independent Director notifies of intention to sell stock

Executive VP & CFO exercised options and sold US$92k worth of stock

Recent updates

InfuSystem Holdings, Inc., Annual General Meeting, May 16, 2024

InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K

InfuSystem Holdings, Inc. announced delayed annual 10-K filing

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board

InfuSystem Holdings, Inc. to Report Q4, 2023 Results on Mar 14, 2024

New minor risk - Shareholder dilution

InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023

InfuSystem Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

CEO & Director exercised options and sold US$870k worth of stock

Consensus EPS estimates fall by 25%, revenue upgraded

InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

InfuSystem Holdings, Inc. to Report Q2, 2023 Results on Aug 03, 2023

President exercised options and sold US$79k worth of stock

Independent Director notifies of intention to sell stock

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Consensus EPS estimates fall by 15%

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023

Executive VP & CFO exercised options and sold US$92k worth of stock

Full year 2022 earnings released: EPS: US$0.001 (vs US$0.069 in FY 2021)

Independent Director exercised options and sold US$101k worth of stock

Independent Director exercised options and sold US$114k worth of stock

Independent Director exercised options and sold US$114k worth of stock

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2022

InfuSystem Holdings, Inc. to Report Q3, 2022 Results on Nov 08, 2022

InfuSystem Holdings, Inc. Announces the Appointment of R. Rimmy Malhotra to Board of Directors, Effective September 20, 2022

Independent Director exercised options and sold US$70k worth of stock

Executive VP & Chief Commercial Officer exercised options and sold US$56k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

InfuSystem Holdings Inc. Revises Earnings Guidance for the Year 2022

InfuSystem Holdings, Inc. to Report Q2, 2022 Results on Aug 04, 2022

InfuSystem Holdings, Inc.(NYSEAM:INFU) dropped from Russell 2000 Dynamic Index

Independent Director exercised options and sold US$206k worth of stock

Executive VP & Chief Commercial Officer exercised options and sold US$119k worth of stock

Independent Director exercised options and sold US$66k worth of stock

InfuSystem Holdings Inc. Approves Appointment of Ralph Boyd to the Company's Board

Consensus EPS estimates fall by 38%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

InfuSystem Holdings Inc. Provides Earnings Guidance for the Year 2022

Price target decreased to US$21.67

InfuSystem Holdings Inc., Annual General Meeting, May 17, 2022

Director exercised options and sold US$175k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 49%

Independent Director recently bought US$107k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

InfuSystem Holdings Inc. to Report Q4, 2021 Results on Feb 10, 2022

CEO & Director notifies of intention to sell stock

Insider exercised options and sold US$101k worth of stock

Third quarter 2021 earnings released: US$0.022 loss per share (vs US$0.15 profit in 3Q 2020)

Independent Director exercised options to buy US$399k worth of stock.

Investor sentiment improved over the past week

Consensus EPS estimates fall to US$0.19

Second quarter 2021 earnings released: EPS US$0.04 (vs US$0.21 in 2Q 2020)

InfuSystem Holdings Inc. Revises Earnings Guidance for the Full Year 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

InfuSystem Holdings Inc. (NYSEAM:INFU) announces an Equity Buyback for $20 million worth of its shares.

Independent Chairman of the Board exercised options to buy US$421k worth of stock.

Infusystem Holdings Inc. Reaffirms Earnings Guidance for Full Year 2021

First quarter 2021 earnings released: EPS US$0.033 (vs US$0.021 loss in 1Q 2020)

CEO & Director exercised options and sold US$576k worth of stock